GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae

Published on December 26, 2024

of meeting specific milestones and subject to availability of funds, further funding may be available to advance the Pre-clinical phase and

Continue reading on website
Other news

Pakistan-China strategic partnership ‘anchor of regional stability’: PM

December 26, 2024
from the China Pakistan Economic Corridor (CPEC) to cultural exchanges, education, defence production.”PM Shehbaz said that the decades-

D-Street small stocks steal the show in 2024, giving handsome returns to investors

December 26, 2024
consumption, and government reforms, ensured resilience in capital markets. While foreign institutional investors (FIIs) engaged in profit-